NIIKI PHARMA
Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics. With a team of experts in cancer drug development and commercialization, Niiki Pharma programs are characterized by quality, speed and capital efficient processes.
NIIKI PHARMA
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
2007-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.niikipharma.com
Total Employee:
11+
Status:
Active
Contact:
813) 910-2120
Email Addresses:
[email protected]
Total Funding:
10.49 M USD
Technology used in webpage:
Domain Not Resolving
Similar Organizations
Epredia
Epredia is a biotechnology company that provides labeling, tracking, pathology, cancer diagnostics and tissue diagnostics services.
OnCirc Diagnostics
OnCirc Diagnostics is a biotechnology company involved in the in vivo diagnostics of circulating tumor cells.
Zalgen Labs
Zalgen Labs is a biotechnology company specializing in the design and production of superior biological molecules.
Current Employees Featured
Founder
Investors List
BioAdvance
BioAdvance investment in Venture Round - Niiki Pharma
BioAdvance
BioAdvance investment in Venture Round - Niiki Pharma
BioAdvance
BioAdvance investment in Venture Round - Niiki Pharma
BioAdvance
BioAdvance investment in Venture Round - Niiki Pharma
BioAdvance
BioAdvance investment in Venture Round - Niiki Pharma
BioAdvance
BioAdvance investment in Debt Financing - Niiki Pharma
BioAdvance
BioAdvance investment in Debt Financing - Niiki Pharma
BioAdvance
BioAdvance investment in Seed Round - Niiki Pharma
More informations about "Niiki Pharma"
Niiki Pharma - Crunchbase Company Profile & Funding
Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics. With a team of โฆSee details»
Niiki Pharma Company Profile 2024: Valuation, Investors
Where is Niiki Pharma headquartered? Niiki Pharma is headquartered in Tampa, FL. What is the size of Niiki Pharma? Niiki Pharma has 50 total employees. What industry is Niiki Pharma in? โฆSee details»
NIIKI PHARMA INC Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for NIIKI PHARMA INC of Hoboken, NJ. Get the latest business insights from Dun & Bradstreet.See details»
Niiki Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Niiki Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, and 4 literature, Drug:NKP-14, NKP-1485(Niiki Pharma, Inc.), NKP-1768, NKP โฆSee details»
Niiki Pharma - Products, Competitors, Financials, Employees ...
Niiki is a cancer drug development company primarily focused on developing three drug candidates which are designed to preferentially target the cancer cells. You're one click away โฆSee details»
Novel First-in-Class Anti-Cancer Agent in Development by Niiki โฆ
Jun 1, 2011ย ยท Niiki Pharma Inc. is an oncology therapeutics development company with a pipeline of novel targeted anti-cancer agents. For more information, visit www.niikipharma.com. About โฆSee details»
Niiki Pharma - Funding, Financials, Valuation & Investors
Niiki Pharma is an oncology company specializing in cancer treatments and companion diagnostics directed at cellular targets.See details»
Niiki Pharma - Crunchbase
Niiki Pharma is an oncology company specializing in cancer treatments and companion diagnostics directed at cellular targets.See details»
Niiki Pharma Inc. - BioCentury Company Profiles - BCIQ
Jun 24, 2013ย ยท Niiki Pharma Inc. - BioCentury Company Profiles for the biopharma industrySee details»
Niiki Pharma - VentureRadar
Niiki Pharma VentureRadar profile. Find out more about Niiki Pharma including the VentureRadar Innovation and Growth scores, Similar Companies and more.See details»
Niiki Pharma - Ben Franklin Technology Partners
Niiki Pharma is a development focused oncology company specializing in first-in-class cancer treatments directed at novel cellular targets and related companion diagnostics. Niiki Pharmaโs โฆSee details»
Niiki Pharma Announces Positive Interim Data from Ongoing
Niiki Pharma Announces Positive Interim Data from Ongoing Clinical Trial of Novel Anti-Cancer Agent. Phase I clinical trial results of the first-in-class cancer agent show 25% of enrolled โฆSee details»
Niiki Pharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore Niiki Pharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 clinical trial, 1 news, Drug:NKP-14, NKP-1485(Niiki Pharma, Inc.), NKP-1768, NKP-1339, NKP-2235.See details»
Niiki Pharma - Contacts, Employees, Board Members ... - Crunchbase
Niiki Pharma is an oncology company specializing in cancer treatments and companion diagnostics directed at cellular targets.See details»
Intezyne Technologies Expands Its Oncology Pipeline Through
TAMPA, Fla., June 19, 2013 (GLOBE NEWSWIRE) -- Intezyne Technologies, a privately held drug development company dedicated to improving the treatment of cancer, announced it has โฆSee details»
Niiki Pharma, Inc. (Niiki Pharma, Inc.) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ โฆ
NKP-1339 is a first-in-class transferrin targeted small molecule that down-regulates GRP78, a key regulator of mis-folded protein processing and a tumor survival factor. NKP-1339 Phase I โฆSee details»
Novel First-in-Class Anti-Cancer Agent in Development by Niiki โฆ
Jun 1, 2011ย ยท Niiki Pharma announced today that it will present interim data from the ongoing Phase I clinical study for its lead product, NKP-1339, at the 2011 American Society for Clinical โฆSee details»
Niiki Pharma Announces Positive Interim Data from Ongoing โฆ
Sep 20, 2011ย ยท HOBOKEN, N.J. and PHILADELPHIA, Sept. 20, 2011 /PRNewswire/ -- Niiki Pharma Inc. announced interim results from the ongoing Phase I clinical trial of its lead โฆSee details»
History & IP - Bold Therapeutics
Niiki Pharma acquired KP1339 (then renamed to NKP-1339) from Momentous Ventures in 2008, who had previously licensed the asset from the University of Vienna. Niiki Pharma began the โฆSee details»
Niiki Pharma Breaks New Ground with Novel Cancer Therapy
Feb 21, 2012ย ยท A first-in-man cancer therapy in development by Niiki Pharma Inc. shows promise in targeting a new pathway known as GRP78. This target repairs damaged or deconstructed โฆSee details»